Federico Grossi - 03 Jan 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol
APLS
Transactions as of
03 Jan 2022
Net transactions value
-$17,741
Form type
4
Filing time
04 Jan 2022, 15:07:25 UTC
Previous filing
17 Dec 2021
Next filing
14 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $17,741 -375 -0.53% $47.31 70,354 03 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.